Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

2’-[18F]Fluoroflumazenil

In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004.
[updated ].
Free Books & Documents
Review

2’-[18F]Fluoroflumazenil

The MICAD Research Team.
Free Books & Documents

Excerpt

Benzodiazepines are used for their sedative, anxiolytic, and muscle-relaxant properties. Their mechanism of action involves the binding of a ligand to a specific benzodiazepine receptor. Alteration of the central benzodiazepine receptor (CBR) has been reported in various diseases and pathologic conditions such as Alzheimer’s disease, epilepsy, or cerebral ischemia (1-4).

CBRs have been studied in vivo by positron emission tomography (PET) and single photon emission computed tomography, and the existence of a specific benzodiazepine receptor linked to the γ-aminobutyric acid (GABA) receptor/chloride ionophore has been shown by use of diazepam (4).

[11C]Flumazenil, a highly selective benzodiazepine antagonist, has been the most widely used agent for PET imaging of CBRs, but the short half-life of 11C (20 min) limits its use. To overcome this great disadvantage, the flumazenil analog [18F]fluoroethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo-[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate ([18F]fluoroflumazenil; [18F]FFMZ) has been developed and is currently under study. It can be conveniently synthesized and labeled, and preliminary research shows some favorable specific binding properties for CBRs.

PubMed Disclaimer

Similar articles

References

    1. Marczynski TJ . GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; pharmacologic profile of the benzodiazepine antagonist, flumazenil. Rev Neurosci. 1995;6(3):221–258. - PubMed
    1. Thomas RJ . Seizures and epilepsy in the elderly. Arch Intern Med. 1997;157(6):605–617. - PubMed
    1. Nutt DJ , Malizia AL . New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001;179:390–396. - PubMed
    1. Mohler H , Okada T . Benzodiazepine receptor: demonstration in the central nervous system. Science. 1977;198(4319):849–851. - PubMed
    1. Yoon YH , Jeong JM , Kim HW , Hong SH , Lee YS , Kil HS , Chi DY , Lee DS , Chung JK , Lee MC . Novel one-pot one-step synthesis of 2'-[(18)F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging. Nucl Med Biol. 2003;30(5):521–527. - PubMed

LinkOut - more resources